Data / Form D filings / ABK Biomedical Inc
ABK Biomedical Inc: Form D filings
ABK Biomedical Inc, a company in Halifax, Nova Scotia, Canada, filed 5 Form D notices with the SEC between 2019 and 2025. The latest, on November 3, 2025, reports $2.6 million sold of a $2.6 million offering to 6 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 155 CHAIN LAKE DRIVE, UNIT 32, Halifax, Nova Scotia, Canada, B3S 1
- Phone
- (902) 442-4009
- Industry
- Other
- Entity type
- Corporation
- Incorporated in
- Nova Scotia, Canada
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1773773
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Nov 3, 2025 | New notice | $2,558,896 | $2,558,896 | 6 | Oct 14, 2025 | sec.gov | |
| May 13, 2025 | New notice | $26,093,999 | $26,093,999 | 24 | Apr 29, 2025 | sec.gov | |
| Dec 22, 2022 | Amendment | $28,498,880 | $28,498,880 | 23 | Dec 5, 2022 | sec.gov | |
| Sep 23, 2022 | New notice | $18,086,680 | $18,086,680 | 16 | Sep 9, 2022 | sec.gov | |
| Apr 22, 2019 | New notice | $23,499,999 | $23,499,999 | 10 | Apr 8, 2019 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Lucy Bellardine Bataneant | Executive Officer | |
| Aravind Arepally | Executive Officer | |
| David Dobrowsky | Executive Officer | |
| Joseph Bellardine Siletto | Director | |
| James Bellardine McLaren | Director | |
| Marc Gregoire | Executive Officer | |
| Aaron Berez | Director | |
| Keten Patel | Director | |
| Anthony Headley | Executive Officer | |
| Carissa Bellardine Black | Director | |
| Mike Tyson | Executive Officer | |
| James Bellardine Eadie | Director | |
| Gary Donofrio | Executive Officer | |
| Michael Mangano | Executive Officer, Director |
Every Form D from the week of Nov 3, 2025 · All recent Other filings
Read from SEC EDGAR. Amount sold is what ABK Biomedical Inc reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.